BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Intellectual Property Office Decisions


You are here: BAILII >> Databases >> United Kingdom Intellectual Property Office Decisions >> Neurim Pharmaceuticals (1991) Ltd (Patent) [2009] UKIntelP o38409 (15 December 2009)
URL: http://www.bailii.org/uk/cases/UKIntelP/2009/o38409.html
Cite as: [2009] UKIntelP o38409

[New search] [Printable PDF version] [Help]


Neurim Pharmaceuticals (1991) Ltd [2009] UKIntelP o38409 (15 December 2009)

For the whole decision click here: o38409

Patent decision

BL number
O/384/09
Concerning rights in
SPC/GB/07/051
Hearing Officer
Mrs C L Davies
Decision date
15 December 2009
Person(s) or Company(s) involved
Neurim Pharmaceuticals (1991) Ltd
Provisions discussed
Regulation (EC) No. 469/2009; Article 3(d)
Keywords
Supplementary Protection Certificates
Related Decisions
None

Summary

Neurim Pharmaceuticals (1991) Ltd filed an application for an SPC for the product melatonin, identifying authorisation EU/1/07/392/001 for the medicinal product Circadin - melatonin as the first authorisation to place the product on the market.

However, the Hearing Officer found that an earlier veterinary authorisation for Regulin having the active ingredient melatonin precluded the grant of an SPC based on the later authorisation for Circadin.

Since the conditions of Article 3(d) of the Regulation have therefore not been met, the Hearing Officer rejected the application for an SPC under Article 10(2).



BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKIntelP/2009/o38409.html